|
1HLL
NMR STRUCTURE OF T3-I2, A 32 RESIDUE PEPTIDE FROM THE ALPHA-2A ADRENERGIC RECEPTOR
Deposited 2000-12-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
118–149(32 aa)
Fragment:SECOND INTRACELLULAR LOOP T3-I2 (RESIDUES 118-149)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 4.5;303 K;Ionic strength (raw mmCIF value) 50 mM NaCl
NMR sample composition
0.9 mM T3-I2 natural abundance; 460 mM D38-dodecylphosphocholine, 50 mM NaCl, 10 mM NaH2PO4, pH 4.5 | 90% H2O/10% D2O
NMR sample composition
0.9 mM T3-I2 natural abundance; 460 mM D38 dodecylphosphocholine, 50 mM NaCl, 10 mM NaH2PO4, pH 4.5 | 100% D2O
|
Resolution not provided
|
|
1HO9
BEST 20 NMR CONFORMERS OF D130I MUTANT T3-I2, A 32 RESIDUE PEPTIDE FROM THE ALPHA 2A ADRENERGIC RECEPTOR
Deposited 2000-12-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
118–149(32 aa)
Fragment:SECOND INTRACELLULAR LOOP (RESIDUES 118-149)
|
Mutation:D130I
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 4.5;303 K;Ionic strength (raw mmCIF value) 50 mM NACL
NMR measurement conditions
pH 4.5;303 K;Ionic strength (raw mmCIF value) 50 mM
NMR sample composition
0.9 mM PEPTIDE NATURAL ABUNDANCE; 460 mM D38- DODECYLPHOSPHOCHOLINE, 50 mM NACL, 10 mM NAH2PO4, PH 4.5 | 90% H2O/10% D2O
NMR sample composition
0.9 mM PEPTIDE NATURAL ABUNDANCE; 460 mM D38- DODECYLPHOSPHOCHOLINE, 50 mM NACL, 10 mM NAH2PO4, PH 4.5 | 100% D20
|
Resolution not provided
|
|
1HOD
NMR STRUCTURE OF D130I MUTANT T3-I2, A 32 RESIDUE PEPTIDE FROM THE ALPHA 2A ADRENERGIC RECEPTOR
Deposited 2000-12-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
118–149(32 aa)
Fragment:SECOND INTRACELLULAR LOOP (RESIDUES 118-149)
|
Mutation:D130I
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 4.5;303 K;Ionic strength (raw mmCIF value) 50 mM NACL
NMR measurement conditions
pH 4.5;303 K;Ionic strength (raw mmCIF value) 50 mM
NMR sample composition
0.9 mM PEPTIDE NATURAL ABUNDANCE; 460 mM D38- DODECYLPHOSPHOCHOLINE, 50 mM NACL, 10 mM NAH2PO4, PH 4.5 | 90% H2O/10% D2O
NMR sample composition
0.9 mM PEPTIDE NATURAL ABUNDANCE; 460 mM D38- DODECYLPHOSPHOCHOLINE, 50 mM NACL, 10 mM NAH2PO4, PH 4.5 | 100 % D20
|
Resolution not provided
|
|
1HOF
NMR STRUCTURE OF T3-I2, A 32 RESIDUE PEPTIDE FROM THE ALPHA-2A ADRENERGIC RECEPTOR
Deposited 2000-12-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
118–149(32 aa)
Fragment:SECOND INTRACELLULAR LOOP (RESIDUES 118-149)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 4.5;303 K;Ionic strength (raw mmCIF value) 50 mM NACL
NMR measurement conditions
pH 4.5;303 K;Ionic strength (raw mmCIF value) 50 mM
NMR sample composition
0.9 MM T3-I2 PEPTIDE NATURAL ABUNDANCE; 460 mM D38- DODECYLPHOSPHOCHOLINE, 50 mM NACL, 10 mM NAH2PO4, PH 4.5 | 90% H2O/10% D2O
NMR sample composition
0.9 MM T3-I2 PEPTIDE NATURAL ABUNDANCE; 460 mM D38- DODECYLPHOSPHOCHOLINE, 50 mM NACL, 10 mM NAH2PO4, PH 4.5 | 100% D2O
|
Resolution not provided
|
|
6K42
cryo-EM structure of alpha2BAR-Gi1 complex
Deposited 2019-05-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain R
1–27(27 aa)
|
Not recorded
|
CZX 4-[(1~{S})-1-(2,3-dimethylphenyl)ethyl]-1~{H}-imidazole × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.10 Å
|
|
7EJ0
Structure of the alpha2A-adrenergic receptor GoA signaling complex
Deposited 2021-04-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain R
1–465(465 aa)
|
Not recorded
|
E5E Noradrenaline × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
7EJ8
Structure of the alpha2A-adrenergic receptor GoA signaling complex bound to brimonidine
Deposited 2021-04-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain R
1–465(465 aa)
|
Not recorded
|
J59 Brimonidine × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.00 Å
|
|
7EJA
Structure of the alpha2A-adrenergic receptor GoA signaling complex bound to dexmedetomidine
Deposited 2021-04-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain R
1–465(465 aa)
|
Not recorded
|
CZX 4-[(1~{S})-1-(2,3-dimethylphenyl)ethyl]-1~{H}-imidazole × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.60 Å
|
|
7EJK
Structure of the alpha2A-adrenergic receptor GoA signaling complex bound to oxymetazoline
Deposited 2021-04-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain R
1–465(465 aa)
|
Not recorded
|
J5C Oxymetazoline × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å
|
|
7W6P
Cryo-EM structure of the alpha2A adrenergic receptor GoA signaling complex bound to a G protein biased agonist
Deposited 2021-12-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain R
1–465(465 aa)
|
Not recorded
|
W96 N-pyridin-4-ylisoquinolin-4-amine × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.47 Å
|
|
7W7E
Cryo-EM structure of the alpha2A adrenergic receptor GoA signaling complex bound to a biased agonist
Deposited 2021-12-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain R
1–465(465 aa)
|
Not recorded
|
W58 5-(3-bicyclo[4.2.0]octa-1,3,5-trienyl)-1,2,3,6-tetrahydropyridine × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å
|
|
9CBL
Cryo-EM structure of epinephrine-bound alpha-2A-adrenergic receptor in complex with heterotrimeric Gi-protein
Deposited 2024-06-19
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain R
35–242(208 aa)
Chain R
380–460(81 aa)
|
Not recorded
|
ALE L-EPINEPHRINE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.80 Å
|
|
9CBM
Cryo-EM structure of dexmedetomidine-bound alpha-2A-adrenergic receptor in complex with heterotrimeric Gi-protein
Deposited 2024-06-19
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain R
35–242(208 aa)
Chain R
380–460(81 aa)
|
Not recorded
|
CZX 4-[(1~{S})-1-(2,3-dimethylphenyl)ethyl]-1~{H}-imidazole × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
9PLN
Locally-refined structure of alpha2a adrenergic receptor in complex with Go heterotrimer, scFv16, and N-(5-methylnaphthalen-1-yl)pyridin-4-amine (compound 4905)
Deposited 2025-07-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain R
2–465(464 aa)
|
Not recorded
|
A1CIU N-(5-methylnaphthalen-1-yl)pyridin-4-amine × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;CHS was solubilized in LMNG and GDN prior to diluting into buffers.
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.80 Å
|
|
9PLO
Structure of alpha2a adrenergic receptor in complex with Go heterotrimer, scFv16, and N-(5-methylnaphthalen-1-yl)pyridin-4-amine (compound 4905)
Deposited 2025-07-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain R
2–465(464 aa)
|
Not recorded
|
A1CIU N-(5-methylnaphthalen-1-yl)pyridin-4-amine × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;CHS was solubilized in LMNG and GDN prior to diluting into buffers.
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.74 Å
|
|
9PQD
Locally-refined structure of alpha2a adrenergic receptor in complex with Go heterotrimer, scFv16, and compound Z7149
Deposited 2025-07-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain R
2–465(464 aa)
|
Not recorded
|
A1CIZ (6M)-1-methyl-6-(1,2,5,6-tetrahydropyridin-3-yl)-1H-indole × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;Buffer was supplemented with 0.01 mM compound Z7149
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.29 Å
|